Source note3 min read

Scaling Up Formal Representation of Clinical Trial Protocols in Ensemble Logic Using LLMs: A Preliminary Study

Source

arXiv

arxiv.org/abs/2607.21307v1

Read the source

Source

Plain-Language Brief

Researchers present CT-TEL workflow, a scalable pipeline that uses Large Language Models (LLMs) to convert clinical trial protocols from unstructured free text into Temporal Ensemble Logic (TEL) formulas. The study tested the translation fidelity of 23 real-world trials and found promising results, suggesting potential for mapping informal protocols to computable logic.

What the Document Says

  • The reliance on unstructured free text for clinical trial protocol documentation creates a barrier for automated reasoning, cohort discovery, and trial simulation due to the lack of formal structure that obscures critical temporal phenotypes like dynamic eligibility criteria and event timing constraints.
  • Temporal Ensemble Logic (TEL) offers an expressive framework for modeling these elements but manual encoding remains a bottleneck.
  • The CT-TEL workflow is introduced as a solution, which is a scalable pipeline leveraging Large Language Models (LLMs) to translate narrative clinical protocols into TEL formulas.
  • The study applied CT-TEL to generate logical models for 23 real-world trials from ClinicalTrials.gov and evaluated translation fidelity via back-translation approach using LLMs.
  • Results suggest that LLMs may offer a pathway for mapping informal protocols to computable logic, providing preliminary evidence toward scalable clinical trial emulation within the emerging 'Symbolic Biomedicine' paradigm.

Key Concepts Mentioned

  • clinical trial protocols
  • unstructured free text
  • automated reasoning
  • cohort discovery
  • trial simulation
  • Temporal Ensemble Logic (TEL)
  • manual encoding bottleneck
  • Large Language Models (LLMs)
  • translation fidelity
  • back-translation
  • Scalable Clinical Trial Emulation
  • Symbolic Biomedicine

Claims Made by the Document

  • Unstructured free text in clinical trial protocol documentation is a barrier for automated reasoning and trial simulation.
  • TEL offers an expressive framework for modeling temporal phenotypes but manual encoding is a bottleneck.
  • CT-TEL workflow using LLMs can translate narrative clinical protocols into TEL formulas.
  • Translation fidelity of CT-TEL was evaluated via back-translation approach.
  • Results suggest that LLMs may offer a pathway for mapping informal protocols to computable logic.
  • CT-TEL provides preliminary evidence toward scalable clinical trial emulation.

Evidence Used

  • The text describes the challenges with unstructured free text and lack of formal structure in clinical trial protocol documentation.
  • The text introduces TEL as a framework for modeling temporal phenotypes, but mentions manual encoding as a bottleneck.
  • The text presents CT-TEL workflow that uses LLMs to translate protocols into TEL formulas.
  • The text explains the back-translation approach used to evaluate translation fidelity of CT-TEL.
  • The text mentions the semantic retention results suggesting potential for mapping informal protocols to computable logic.

Methods / Approach

UNKNOWN

Limitations Stated by the Authors

UNKNOWN

Limitations Noted by the Agent

Agent interpretation — not from the source.

UNKNOWN

Open Questions

UNKNOWN

Notes for Future Q&A

May include interpretation. Labeled where it does.

UNKNOWN

Raw Abstract / Excerpt

The reliance on unstructured free text for documenting clinical trial protocols creates a significant barrier to automated reasoning, cohort discovery, and trial simulation. The lack of formal structure obscures critical temporal phenotypes, such as dynamic eligibility criteria and event timing constraints. Although Temporal Ensemble Logic (TEL) offers an expressive framework for modeling these elements, manual encoding remains a prohibitive bottleneck. We introduce the CT-TEL workflow: a scalable pipeline leveraging Large Language Models (LLMs) to translate narrative clinical protocols into TEL formulas. We applied CT-TEL to generate logical models for 23 real-world trials from ClinicalTrials.gov. We evaluated translation fidelity via a back-translation approach, using LLMs to convert TEL formulas back into natural language and measuring semantic similarity against source texts. The resulting semantic retention suggests that LLMs may offer a pathway for mapping informal protocols to computable logic, providing preliminary evidence toward scalable clinical trial emulation within the emerging 'Symbolic Biomedicine' paradigm championed by the corresponding author.